Popular Trials
Stem Cell Transplant
Bone Marrow/Kidney Transplant for Blood Disorders & Chronic Kidney Disease
Recruiting1 award11 criteria
Boston, Massachusetts
This trial is for a combined bone marrow and kidney transplant from a partially matched related donor to treat a blood disorder and kidney disease. The expectation is to have 10 people participate.
CAR T-cell Therapy
TAA-Specific CTL Therapy for Lymphoma
Recruiting1 awardPhase 1
Houston, Texas
This trial is for patients who have a type of lymph gland disease called Hodgkin or non-Hodgkin lymphoma which has come back, or may come back, or has not gone away after treatment. This is a research study using special immune system cells called tumor associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy.
Stem Cell Transplantation
Stem Cell Transplant for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial is testing a new two-step approach to treating high-risk non-Hodgkin's lymphoma. First, the patient's own blood cells are transplanted. Then, a transplant from another individual is performed. The goal is to improve the chances for long-term control of lymphoma.
Popular Filters
Trials for B-Cell Lymphoma Patients
Checkpoint Inhibitor
Relatlimab + Nivolumab for Lymphoma
Recruiting1 awardPhase 1 & 2
Phoenix, Arizona
This trial is testing two drugs, relatlimab and nivolumab, in children and young adults whose lymphoma has come back or didn't respond to other treatments. These drugs help the immune system recognize and attack cancer cells. The study aims to see if this combination is safe and effective. Nivolumab has demonstrated clinical benefits in multiple tumors, including classical Hodgkin lymphoma.
Acupuncture for Pain Management in Lymphoma
Recruiting2 awardsPhase 3
New York, New York
This trial is investigating whether acupuncture can help reduce the need for opioid painkillers in patients experiencing pain from chemotherapy. Acupuncture involves inserting thin needles into specific points on the body to relieve pain. The study aims to see if this method can lessen pain and improve quality of life for these patients.
AH-HA EHR Tool for Heart Health in Cancer Survivors
Recruiting1 award6 criteria
Cedar Rapids, Iowa
This trial is looking at the effects of a tool that uses electronic health records to help cancer survivors manage their cardiovascular health. The study will compare how well the tool works compared to usual care in terms of risk reduction and health promotion activities.
Monoclonal Antibodies
Favezelimab + Pembrolizumab for Lymphoma
Recruiting1 awardPhase 1 & 2
Gilbert, Arizona
This trial will study the safety and effectiveness of two drugs, favezelimab and pembrolizumab, when used alone or in combination to treat people with classical Hodgkin lymphoma, diffuse large B-cell lymphoma, and indolent non-Hodgkin lymphoma.
Trials for Large B-Cell Lymphoma Patients
Checkpoint Inhibitor
Relatlimab + Nivolumab for Lymphoma
Recruiting1 awardPhase 1 & 2
Phoenix, Arizona
This trial is testing two drugs, relatlimab and nivolumab, in children and young adults whose lymphoma has come back or didn't respond to other treatments. These drugs help the immune system recognize and attack cancer cells. The study aims to see if this combination is safe and effective. Nivolumab has demonstrated clinical benefits in multiple tumors, including classical Hodgkin lymphoma.
Acupuncture for Pain Management in Lymphoma
Recruiting2 awardsPhase 3
New York, New York
This trial is investigating whether acupuncture can help reduce the need for opioid painkillers in patients experiencing pain from chemotherapy. Acupuncture involves inserting thin needles into specific points on the body to relieve pain. The study aims to see if this method can lessen pain and improve quality of life for these patients.
AH-HA EHR Tool for Heart Health in Cancer Survivors
Recruiting1 award6 criteria
Cedar Rapids, Iowa
This trial is looking at the effects of a tool that uses electronic health records to help cancer survivors manage their cardiovascular health. The study will compare how well the tool works compared to usual care in terms of risk reduction and health promotion activities.
Trials for CD30 Positive Patients
Monoclonal Antibodies
SGN-35T for Lymphoma
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
CAR T-cell Therapy
Immunotherapy for Lymphoma
Recruiting1 awardPhase 1 & 2
Milwaukee, Wisconsin
This trial tests a new treatment where a patient's immune cells are enhanced to better fight cancer. It targets adults whose CD30+ cancer has come back or resisted other treatments. The enhanced cells are designed to specifically attack cancer cells, making the immune system more effective against the disease.
Trials for CD20 Positive Patients
T-Cell Bispecific Antibody
Glofitamab + Obinutuzumab for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Ann Arbor, Michigan
This trial tests glofitamab, a new drug given through an IV that helps immune cells attack cancer cells. It targets patients who need new treatment options because their cancer hasn't responded to existing treatments. The drug works by connecting immune cells to cancer cells, making it easier for the immune system to destroy the cancer. Glofitamab shows promise in treating certain types of blood cancers.
Monoclonal Antibodies
Atezolizumab + BTCT4465A (Mosunetuzumab) for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is testing a new drug called Mosunetuzumab, both alone and with another drug called atezolizumab, in patients with blood cancers that have not responded to other treatments. These drugs work by helping the immune system find and destroy cancer cells. Atezolizumab is a medication that has been approved for use in various cancers, including breast cancer, and has shown effectiveness when combined with other treatments.
Monoclonal Antibodies
Mosunetuzumab + Polatuzumab Vedotin for Aggressive B-Cell Lymphoma
Recruiting2 awardsPhase 3
Hamilton, Ontario
This trial will compare the effectiveness of mosunetuzumab+polatuzumab vedotin to rituximab+gemcitabine+oxaliplatin in people with relapsed or refractory DLBCL, high-grade B-cell lymphoma, transformed follicular lymphoma, and FL3B.
Phase 3 Trials
Acupuncture for Pain Management in Lymphoma
Recruiting2 awardsPhase 3
New York, New York
This trial is investigating whether acupuncture can help reduce the need for opioid painkillers in patients experiencing pain from chemotherapy. Acupuncture involves inserting thin needles into specific points on the body to relieve pain. The study aims to see if this method can lessen pain and improve quality of life for these patients.
Monoclonal Antibodies
Mosunetuzumab + Polatuzumab Vedotin for Aggressive B-Cell Lymphoma
Recruiting2 awardsPhase 3
Hamilton, Ontario
This trial will compare the effectiveness of mosunetuzumab+polatuzumab vedotin to rituximab+gemcitabine+oxaliplatin in people with relapsed or refractory DLBCL, high-grade B-cell lymphoma, transformed follicular lymphoma, and FL3B.
Anti-metabolites
Brentuximab Vedotin + Chemotherapy for Hodgkin's Lymphoma
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial is studying brentuximab vedotin in combination with chemotherapy to see if it is more effective than chemotherapy alone in treating children with high risk Hodgkin lymphoma.
Trials With No Placebo
Checkpoint Inhibitor
Relatlimab + Nivolumab for Lymphoma
Recruiting1 awardPhase 1 & 2
Phoenix, Arizona
This trial is testing two drugs, relatlimab and nivolumab, in children and young adults whose lymphoma has come back or didn't respond to other treatments. These drugs help the immune system recognize and attack cancer cells. The study aims to see if this combination is safe and effective. Nivolumab has demonstrated clinical benefits in multiple tumors, including classical Hodgkin lymphoma.
Acupuncture for Pain Management in Lymphoma
Recruiting2 awardsPhase 3
New York, New York
This trial is investigating whether acupuncture can help reduce the need for opioid painkillers in patients experiencing pain from chemotherapy. Acupuncture involves inserting thin needles into specific points on the body to relieve pain. The study aims to see if this method can lessen pain and improve quality of life for these patients.
AH-HA EHR Tool for Heart Health in Cancer Survivors
Recruiting1 award6 criteria
Cedar Rapids, Iowa
This trial is looking at the effects of a tool that uses electronic health records to help cancer survivors manage their cardiovascular health. The study will compare how well the tool works compared to usual care in terms of risk reduction and health promotion activities.
Monoclonal Antibodies
Favezelimab + Pembrolizumab for Lymphoma
Recruiting1 awardPhase 1 & 2
Gilbert, Arizona
This trial will study the safety and effectiveness of two drugs, favezelimab and pembrolizumab, when used alone or in combination to treat people with classical Hodgkin lymphoma, diffuse large B-cell lymphoma, and indolent non-Hodgkin lymphoma.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.